99113144 - ASCENTAGE

Information

• Trademark
• 99113144

• Source

• Serial Number

  99113144

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  March 31, 2025
  10 months ago

• Transaction Date

  April 01, 2025
  9 months ago

• Status Date

  March 31, 2025
  10 months ago

• Status Code

  630

• Attorney Docket Number

  ASCNT-21-128

  Attorney Name

  Kathryn E. Smith

• Owners

  • ASCENTAGE PHARMA (SUZHOU) CO.,LTD.

Case File Statements

• DM0000: The mark consists of the word Ascentage in a stylized font with two arc-shaped lines appearing above and underneath the first "A", and the center line of the first "A" appearing as a diagonal line extending above the letters "sce" of Ascentage.
• GS0051: Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases,; fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets

Case File Event Statements

• 3/31/2025 - 10 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/31/2025 - 10 months ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR